Drug Profile
Naltrexone depot - elbion
Alternative Names: NaltrelLatest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator DrugAbuse Sciences
- Developer elbion NV
- Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alcoholism; Opioid-related disorders
Most Recent Events
- 19 Jan 2007 elbion NV acquires naltrexone depot from DrugAbuse Sciences
- 14 Jun 2006 This compound is still in active development for alcoholism and opioid abuse
- 14 Jun 2006 No development reported - Phase-II for Heroin abuse in USA (IM)